¡°	IBS D utilizing alosetron	16.692143180910108
	severe IBS D	14.093675184968296
¡°	alosetron hydrochloride	13.487141889977332
	severe diarrhea predominant IBS	12.939691604880883
¡°	reintroduce Lotronex	12.756470328458478
	constipation predominant IBS	12.639357373354517
	IBS C	11.044751823854195
	less often mixed IBS	11.042822496224897
	IBS M	11.042660019469018
	IBS A	11.028699754530326
	diarrhea predominant female IBS patient	9.399713591825597
¡°	Lotronex incidence	7.9044650162355765
¡°	Lotronex label	7.894186377254811
	nonconstipate female IBS patient experience least moderate baseline pain	6.199183546163109
¡°	diarrhea predominant irritable bowel syndrome utilize alosetron	5.530889684118842
	reintroduction	4.118251294731939
	predominant constipation	4.031012070487444
	woman	2.5844696433109347
	chronic symptom	2.0650053194955076
	ANDA product	1.2456519871968559
	constipation indication	1.1093502017327443
	least moderate pain	0.9129190157175292
	patient symptom	0.8890778626828317
	Assignee	0.8252550347277262
	Reexamined	0.8252550347277262
	Non constipate Female Irritable Bowel Syndrome	0.598386560200287
	Risk Evaluation Mitigation Strategies	0.5501700231518175
	antagonism	0.47602892378273676
	Closures	0.47602892378273676
	doctor	0.4442310493976404
	severe incident	0.44230808146660927
	MeadWestVaco Corp.	0.4126275176361158
	constellation	0.4126275173638631
	REMS	0.4126275173638631
	complication	0.3997369912169202
	attendant physician	0.3850816305165263
	Terence Kennedy Inst	0.33816286510961735
	patient population	0.21867116984508414
	death	0.16412531722688067
	patent.2	0.16412531722688067
	cautionary step	0.15878870729553005
	Fairchild Semiconductor	0.11327803249512958
	Ex Parte Reexamination Certificate	0.09577540531021031
	marketing	0.08899639347327828
	call black box warning	0.08222088474075967
	Treatment	0.06889076626441637
	Orange Book	0.06539398043412734
	long feel unmet need	0.06244192973613082
	reexamined	0.058822284877496765
	J.A.	0.05842290649533292
	obviousness type double patenting	0.05642986242715271
	great efficacy	0.049691997552623636
	conventional therapy	0.04658497452167682
	reexamination certificate	0.044498798111398154
	pharmaceutically acceptable derivative	0.04396241891624378
	hydrochloride salt form	0.04365297459829514
	risk management program	0.04235543286872955
	nexus	0.040542105533955694
	risk profile	0.039163499370524484
	restrictive label	0.03510091181867601
	great six month	0.03289351815520614
	least six month	0.0322982417682662
	administration	0.0322392712155117
	New Jersey	0.030555737428566543
	treatment	0.0264817436291044
	drug commercial success	0.02425018393958515
	ex parte reexamination	0.023846261518461184
	artificial act	0.023386982477030357
	FDA	0.016687019618149543
	unexpected result	0.016434855489746193
	drug potential side effect	0.016224320588436557
	paragraph IV certification	0.01604957932872298
	serious side effect	0.013652623201710524
	assignee	0.01169296812969551
	nonobviousness	0.010753410720571035
	defendant appellee	0.01036029307325857
	inter alia	0.009641688463244544
	prior removal	0.009137047229434786
	clinical improvement	0.00880745692993013
	approval	0.00873604685392821
	adverse event	0.007927650354782517
	Food Drug Administration	0.007654738471048897
	Abbreviated New Drug Application	0.0071977261921805456
	active pharmaceutical ingredient	0.007116632641557169
	secondary consideration	0.00644204736119775
	proof	0.005768420144891479
	priority date	0.0056948279067753444
	instruct	0.0040021527233771404
	October	0.0031058835986228985
	limited evidence	0.00293218435206476
	sale	0.002674596282345324
	effective amount	0.0025216283018981655
	burden	0.002500032036444254
	effective filing date	0.0019030162026329564
	Teleflex Inc.	0.0017461779300432985
	November	0.0015952707760438286
	generic version	0.0013700080766785652
	expect result	0.0013250355190567006
	Idaho Obviousness	0.001133866768668387
	bench trial	0.001120603880930429
	citation	0.0009981153336538896
	content	0.0009219050352367359
	amend	0.0008795897517623101
	factor	0.0007924998665254726
	method	0.00035061043263645846
	failure	0.00023719456893625253
	respect	0.00018425823342688036
	background information	0.0001799926590538341
	underlie factual finding	0.0001357749646814327
	invalidity ruling	0.00013139717565086918
	holding	0.00012197172735592392
	ordinary skill	8.429551558307567e-05
	example	8.380116394044929e-05
	limitation	5.049509448457647e-05
	know element	3.707642231491514e-05
	level	3.4534864380153444e-05
	jurisdiction	3.358135817540322e-05
	law de novo	2.7706009331909206e-05
	various prior art reference	2.664632226938304e-05
	Claim	2.5256261901011695e-05
	clear error	2.4003192121375656e-05
	analysis	2.3634000574290796e-05
	difference	1.8890135842401757e-05
	suit	1.696672828285942e-05
	know way	8.296785122742e-06
	district court conclusion	1.7942093243995798e-06
	light	1.35987373065164e-06
	scope	1.1811069719894598e-06
	assert	1.0352531117725132e-06
	district court decision	8.785485007781464e-07
	action	2.4021179159534567e-07
	question	2.7311907899883204e-08
	invention	2.8331362169510153e-09
	issue	2.4419592084955633e-09
	District	0.0
	Court	0.0
	Appeals	0.0
